Barry Buzogany, Esq. Email & Phone Number

Carolina Beach, Nc, Us

Raleigh-Durham, North Carolina Area

A clinical stage drug development company whose small molecule compound is a Phase 3-ready therapeutic with a novel mechanism of action for the treatment of Alzheimer's Disease. Dramatic preliminary test results were shown in a Phase 2a clinical trial. A Series B extension financing was closed in late 2019. The Company was also awarded a $9M grant from NIH/NIA in 2019. First subjects were enrolled in the Phase 2b trial in early 2020. I serve on the Compensation Committee of the Board, as Assistant Corporate Secretary, and as a business consultant to the Company. See www.T3DTherapeutics.com

Wilmington, North Carolina, United States

OpiAid is an early stage company providing opioid addiction treatment centers with data science solutions to improve clinical outcomes. See www.opiaid.tech

Research Triangle Park, Nc

GeneCoda™ is an executive and professional search and recruitment firm. Its focus is US recruitment in the Life Sciences sector including Pharmaceutical, Biotechnology, Medical Device and Diagnostic companies.

Wilmington, North Carolina

Champaign Il

A Phase 2a stage specialty pharmaceutical company focused on reformulating and repurposing drugs utilizing human microbiome genome enabled pathways. The Company has patented the treatment of disease states caused by or made worse by dysbiosis, including the effects of antibiotic resistance, using a nanosized orally administered drug to inhibit quorum sensing dependent virulence mechanisms of targeted pathogens..

Raleigh-Durham, North Carolina Area

The NACD is an educational and professional development organization for corporate directors. As the recognized authority on leading boardroom practices, NACD enhances directors’ ability to lead with confidence in the boardroom and to competently fulfill their roles to enhance the value of the enterprise.

Wilmington, North Carolina Area

A state-funded nonprofit whose mission was to facilitate collaboration on emerging marine technologies among universities, industry, and funding organizations to commercialize new scientific discoveries for the benefit of North Carolina and beyond.

Louisville, Kentucky

Served as a board member for two years and then as Chairman of the statutory Board of Directors from January 2013 - May 2014. Filled an Advisory role thereafter. PillGuard is developing a novel Rx medication dispensing device designed to address prescription drug abuse. Launched a pilot marketing program in 2014.

Durham, Nc

A founding mentor in this formal program adapted by CED from MIT. Mentored a medical device company in Wilmington, NC developing a treadle device to improve circulation in the lower extremities. Former mentor to three RTP area companies: a nanotechnology company developing novel x-ray sources for a variety of applications; a medical device company developing novel surgical instruments; and a hybrid vehicle company developing a solar/battery assist pedal vehicle.

Nc And Va

ESUCP is a lifelong partner to children, adults, and their families managing disabilities and mental health challenges. With a $90M annual budget, ESUCP of NC and VA is among the largest not-for-profit agencies in the country. Actively served on the Audit, Governance and Executive Committees.

Cary, Nc

A SaaS company providing strategic business intelligence solutions to the Fortune 1000. The company was acquired in 2012.

Research Triangle Park, Nc

Specialty pharmaceutical company developing repurposed drugs and new chemical entities to treat diseases associated with chronic organ (liver, kidney lung) inflammation. I was responsible for the strategic direction of the company, for managing day-to-day operations, including capital formation. As a result of my leadership and bootstrapping skills the company was positioned well to close a subsequent deal through which the company was acquired.

Research Triangle Park, Nc

Icoria, Inc. (formerly Paradigm Genetics) was a publicly traded, genomics based company focused on the discovery and validation of genes, targets and biomarkers for the discovery and development of drugs, diagnostics, and novel agrichemicals. Led the internal and external teams that divested the ag-genomics assets to Monsanto in 2005, and merged the pharma support services business into Clinical Data, Inc. in 2006.

Gaithersburg, Md

A publicly traded supplier of genomic information and bioinformatic tools used by pharma and life sciences companies in drug discovery and development. Successfully defended a "bet the farm" patent infringement lawsuit. Served as both business and legal adviser to Management and to the Board of Directors.

A publicly traded biopharmaceutical company. Joined the company as it transitioned from an R&D/outlicensing company to a fully integrated commercial company. Played a key role in the FDA approval, launch and sale of the company's first two company-marketed drug products. One product, Remicade, was a blockbuster. Drafted and negotiated all commercial agreements to enable the manufacture, supply and international sale of marketed products, as well as to further ongoing clinical trials and R&D collaborations. The Company was acquired by Johnson&Johnson in 2000.

Gaithersburg, Md

A new entrant into the U.S. pharma marketplace in '92. Negotiated key commerial licensing and partnering deals which grew sales exponentially between '92 and '98. A voting member of the joint Steering Committee which managed the Phase III clinical trials, marketing strategy and commercial launch of Coreg, a blockbuster heart drug, in partnerhship with SmithKline Beecham (now GlaxoSmithKline). The company was acquired by Roche in '98.